Archive for the ‘Arthritis’ Category
Wednesday, April 9th, 2008
Bristol-Myers Squibb Company (NYSE: BMY)today announced that the U.S. Food and Drug Administration (FDA) has approved ORENCIA® (abatacept) for reducing signs and symptoms in pediatric patients six years and older with moderately to severely active polyarticular juvenile idiopathic arthritis (JIA). ORENCIA may be used as monotherapy or concomitantly with methotrexate ...
Posted in Arthritis | No Comments »
Wednesday, April 9th, 2008
New data demonstrate that ACZ885, a human monoclonal antibody in Phase III development, achieves long-lasting clinical remission in patients with genetic autoinflammatory diseases1,2. The results indicate that ACZ885 could develop into a major therapeutic advance in the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), a group of rare but serious life-long ...
Posted in Arthritis | No Comments »
Tuesday, April 8th, 2008
Time to take your life back - that's Arthritis Care's message to 7.8 million* people in the UK who live with chronic day-to-day pain. The 61-year old charity today marks its awareness week (12th-18th April) by launching its new Challenging Pain programme across the country.. Around half of those living ...
Posted in Arthritis | No Comments »
Tuesday, April 8th, 2008
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a drug's effect on inhibiting/slowing the progression of structural damage and reducing the signs and symptoms of rheumatoid arthritis during the first year of treatment are the attributes that ...
Posted in Arthritis | No Comments »
Thursday, April 3rd, 2008
Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, reports that a confirmatory Phase IIb trial is now enrolling patients as part of the ongoing development of CF101. The regulatory process in which the Company was involved during the past few months resulted in approvals for ...
Posted in Arthritis | No Comments »
Tuesday, March 25th, 2008
The European Medicines Agency (EMEA) has been formally notified byNeurochem Luxco II SARL of its decision to withdraw the application fora centralised marketing authorisation for the medicine Kiacta(eprodisate disodium) capsules.Kiacta was expected to be used for the treatment of amyloid Aamyloidosis, a rare, life-threatening disease that occurs in patientswith long-lasting ...
Posted in Arthritis | No Comments »
Thursday, March 20th, 2008
Patients with rheumatoid arthritis treated with ACTEMRA™ (tocilizumab) experienced a rapid and significant reduction in the signs and symptoms of their disease, according to a study published in this week's issue of The Lancet. Results from the OPTION (TOcilizumab Pivotal Trial in Methotrexate Inadequate respONders) trial a ...
Posted in Arthritis | No Comments »
Wednesday, March 19th, 2008
In a recent issue of The Johns Hopkins Arthritis Bulletin, Johns Hopkins specialists reported on the latest research regarding the link between rheumatoid arthritis and heart health. With rheumatoid arthritis, the inflammation that damages joints also takes a toll on the heart. Johns Hopkins specialists offer bottom line advice on ...
Posted in Arthritis | No Comments »
Tuesday, March 11th, 2008
Researchers at the University of Michigan Health System have found a key linkage between pain and a specific brain molecule, a discovery that lends new insight into fibromyalgia, an often-baffling chronic pain condition.In patients with fibromyalgia, researchers found, pain decreased when levels of the brain molecule called glutamate went down. ...
Posted in Arthritis | No Comments »
Tuesday, March 11th, 2008
Osteoarthritis (OA) is known as the "wear and tear" arthritis, effecting millions of people. Patients seeking relief from this disease are often sent for a magnetic resonance image (MRI) to diagnose their problem. A new study revealed today at the 75th Annual Meeting of the American Academy of Orthopaedic Surgeons ...
Posted in Arthritis | No Comments »